0001562180-23-001533.txt : 20230217
0001562180-23-001533.hdr.sgml : 20230217
20230217180958
ACCESSION NUMBER: 0001562180-23-001533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ordentlich Peter
CENTRAL INDEX KEY: 0001594274
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37708
FILM NUMBER: 23644443
MAIL ADDRESS:
STREET 1: C/O SYNDAX PHARMACEUTICALS, INC.
STREET 2: 400 TOTTEN POND ROAD, SUITE 140
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Syndax Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001395937
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 320162505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-419-1400
MAIL ADDRESS:
STREET 1: 35 GATEHOUSE DRIVE
STREET 2: BUILDING D, FLOOR 3
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2023-02-15
false
0001395937
Syndax Pharmaceuticals Inc
SNDX
0001594274
Ordentlich Peter
C/O SYNDAX PHARMACEUTICALS, INC.
35 GATEHOUSE DRIVE, BUILDING D, FLOOR 3
WALTHAM
MA
02451
false
true
false
false
Chief Scientific Officer
Common Stock
2023-02-15
2023-02-15
4
M
false
7572.00
6.38
A
7572.00
D
Common Stock
2023-02-15
2023-02-15
4
S
false
7572.00
25.8437
D
0.00
D
Common Stock
2023-02-15
2023-02-15
4
M
false
17428.00
7.20
A
17428.00
D
Common Stock
2023-02-15
2023-02-15
4
S
false
17428.00
25.8437
D
0.00
D
Stock Options (Right to buy)
7.20
2023-02-15
4
M
false
17428.00
25.8437
D
2025-06-01
Common Stock
17428.00
0.00
D
Stock Options (Right to buy)
6.38
2023-02-15
4
M
false
7572.00
25.8437
D
2029-02-06
Common Stock
7572.00
0.00
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Following the sales reported in this Form 4, the Reporting Person has a total of 443,841 options to purchase shares of common stock that are vested and immediately exercisable and a total of 202,500 options to purchase shares of common stock that have not yet vested.
The sale prices ranged from $25.53 to $26.10.
This option is fully vested.
/s/ Michael A. Metzger, Attorney-in-Fact
2023-02-17